Status:

COMPLETED

Repeated Transcranial Magnetic Stimulation in the Elderly With Cognitive Impairment

Lead Sponsor:

Taipei Hospital, Ministry of Health and Welfare

Conditions:

Dementia

Cognitive Impairment, Mild

Eligibility:

All Genders

60+ years

Phase:

NA

Brief Summary

Introduction and Purpose: In recent years, non-pharmacological treatment methods for dementia patients have been gradually explored. Among these, Transcranial Magnetic Stimulation (TMS) has been prop...

Eligibility Criteria

Inclusion

  • Age 60 and above.
  • Have received at least 2 years of education.
  • Diagnosed with dementia or Mild Cognitive Impairment (MCI).
  • Clinical Dementia Rating (CDR) score of ≥0.5.

Exclusion

  • Mental illness.
  • Alcohol or substance addiction.
  • History of heart rhythm disorders.
  • History of epilepsy.
  • History of brain injury.
  • Underwent neurosurgery.

Key Trial Info

Start Date :

July 26 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 19 2024

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT06192433

Start Date

July 26 2023

End Date

June 19 2024

Last Update

November 21 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Taipei Hospital, Ministry of Health and Welfare

New Taipei City, ROC, Taiwan, 24213

Repeated Transcranial Magnetic Stimulation in the Elderly With Cognitive Impairment | DecenTrialz